PRK1 distribution in normal tissues and carcinomas: overexpression and activation in ovarian serous carcinoma
- 31 October 2009
- journal article
- Published by Elsevier BV in Human Pathology
- Vol. 40 (10), 1434-1440
- https://doi.org/10.1016/j.humpath.2009.02.008
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulationNature, 2007
- Reciprocal regulation of 5α-dihydrotestosterone, Interleukin-6 and interleukin-8 during proliferation of epithelial ovarian carcinomaCancer Biology & Therapy, 2007
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell lineGynecologic Oncology, 2005
- Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition AnalysisClinical Cancer Research, 2004
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Genome-wide expression monitoring in Saccharomyces cerevisiaeNature Biotechnology, 1997
- Expression monitoring by hybridization to high-density oligonucleotide arraysNature Biotechnology, 1996
- Serum gonadotropins and steroid hormones and the development of ovarian cancerJAMA, 1995
- Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasInternational Journal of Cancer, 1995